NPAS3
Neuronal PAS domain-containing protein 3
Protein Summary
May play a broad role in neurogenesis. May control regulatory pathways relevant to schizophrenia and to psychotic illness (By similarity). This gene encodes a member of the basic helix-loop-helix and PAS domain-containing family of transcription factors. The encoded protein is localized to the nucleus and may regulate genes involved in neurogenesis. Chromosomal abnormalities that affect the coding potential of this gene are associated with schizophrenia and cognitive disability. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
- ENST00000346562
- ENSP00000319610
- ENSG00000151322
- ENST00000356141
- ENSP00000348460
- ENST00000357798
- ENSP00000350446
- ENST00000547068
- ENSP00000449542
- ENST00000548645
- ENSP00000448916
- BHLHE12
- MOP6
- PASD6
- MOP6
- PASD6
- bHLHe12
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
trait | 1 | ||
phenotype | 0.85 | ||
protein domain | 0.73 | ||
disease | 0.68 | ||
biological process | 0.64 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 48.74 (req: < 5)
Gene RIFs: 24 (req: <= 3)
Antibodies: 122 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 48.74 (req: >= 5)
Gene RIFs: 24 (req: > 3)
Antibodies: 122 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 6
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0